Pharmacokinetics and immunogenicity of CG53135-05 for the prevention of oral mucositis in patients undergoing high-dose chemotherapy and autologous haematopoietic stem cell transplantation

被引：0
|
作者：
Schuster, MW [1 ]
Shore, TB [1 ]
Harpel, J [1 ]
Greenberg, J [1 ]
Jalilizeinali, B [1 ]
Possley, S [1 ]
Annino, V [1 ]
Hawthorne, T [1 ]
Halvorsen, Y [1 ]
机构：
[1] Cornell Univ, Weill Med Coll, New York, NY USA
来源：
BONE MARROW TRANSPLANTATION | 2005年 / 35卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S99 / S99
页数：1
相关论文
共 50 条
  • [1] Phase I trial of CG53135-05 to prevent mucositis in patients undergoing high-dose chemotherapy (HDCT) and autologous peripheral blood stem cell transplantation (PBSCT)
    Schuster, MW
    Shore, TB
    Harpel, J
    Greenberg, J
    Jalilizeinali, B
    Possley, S
    Halvorsen, YD
    Annino, VI
    Hahne, W
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 91 - 91
  • [2] Phase I trial of CG53135-05 to prevent mucositis in patients undergoing high-dose chemotherapy (HDCT) and autologous peripheral blood stem cell transplantation (PBSCT).
    Schuste, MW
    Shore, TB
    Greenberg, J
    Jalilizeinali, B
    Possley, S
    Halvorsen, YD
    Annino, V
    Hahne, W
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 599S - 599S
  • [3] Phase I trial of CG53135-05 to prevent mucositis in patients undergoing high-dose chemotherapy (HDCT) and autologous peripheral blood stem cell transplantation (PBSCT).
    Schuster, MW
    Shore, TB
    Greenberg, J
    Jalilizeinali, B
    Possley, S
    Annino, VI
    Hahne, W
    [J]. BLOOD, 2004, 104 (11) : 329A - 329A
  • [4] Safety and tolerability of velafermin (CG53135-05) in patients receiving high-dose chemotherapy and autologous peripheral blood stem cell transplant
    Michael W. Schuster
    Tsiporah B. Shore
    John G. Harpel
    June Greenberg
    Bita Jalilizeinali
    Scott Possley
    Robert W. Gerwien
    William Hahne
    Yuan-Di C. Halvorsen
    [J]. Supportive Care in Cancer, 2008, 16 : 477 - 483
  • [5] Safety and tolerability of velafermin (CG53135-05) in patients receiving high-dose chemotherapy and autologous peripheral blood stem cell transplant
    Schuster, Michael W.
    Shore, Tsiporah B.
    Harpel, John G.
    Greenberg, June
    Jalilizeinali, Bita
    Possley, Scott
    Gerwien, Robert W.
    Hahne, William
    Halvorsen, Yuan-Di C.
    [J]. SUPPORTIVE CARE IN CANCER, 2008, 16 (05) : 477 - 483
  • [6] New approaches for reduction of oral mucositis in patients undergoing high-dose chemotherapy with haematopoietic stem cell support
    Collova', E
    Castagna, L
    Nozza, A
    Perfetti, V
    Patrone, F
    Danova, M
    Santoro, A
    [J]. BONE MARROW TRANSPLANTATION, 2004, 33 : S323 - S324
  • [7] A randomised placebo-controlled study evaluating the effect of oral zinc for the prevention of mucositis in lymphoma patients undergoing high-dose chemotherapy and autologous stem cell transplantation
    Skaat, A.
    Nagler, A.
    Shimoni, A.
    Koren-Michowitz, M.
    [J]. BONE MARROW TRANSPLANTATION, 2009, 43 : S312 - S312
  • [8] Prevention of oral mucositis with palifermin in patients treated with high-dose chemotherapy and autologous stem cell transplantation. A single center experience.
    Luthi, Francois
    Berwert, Lorenzo
    Frossard, Valerie
    Marchetti, Oscar
    Rosselet, Anne
    Duchosal, Michel
    Ketterer, Nicolas
    [J]. BLOOD, 2006, 108 (11) : 843A - 843A
  • [9] Effects of cryotherapy on high-dose melphalan-induced oral mucositis in pediatric patients undergoing autologous stem cell transplantation
    Kawaguchi, Koji
    Umeda, Katsutsugu
    Takachi, Takayuki
    Ogura, Taemi
    Horikoshi, Yasuo
    Saida, Satoshi
    Kato, Itaru
    Hiramatsu, Hidefumi
    Adachi, Souichi
    Takita, Junko
    Watanabe, Kenichiro
    [J]. PEDIATRIC BLOOD & CANCER, 2020, 67 (09)
  • [10] Oral mucositis as an important factor influencing early complications in patients after high-dose chemotherapy and autologous stem cell transplantation
    Przewozna, I
    Harendarz, A
    Komarnicki, M
    [J]. BONE MARROW TRANSPLANTATION, 2006, 37 : S289 - S289
12345